The HIV-1 envelope (Env) is comprised by mass of over 50% glycans. A goal of HIV-1 vaccine development is the induction of Env glycan-reactive broadly neutralizing antibodies (bnAbs). The 2G12 bnAb recognizes an Env glycan cluster using a unique variable heavy (VH) domain-swapped conformation that results in fragment antigen-binding (Fab) dimerization. Here we describe Fab-dimerized glycan (FDG)-reactive antibodies without VH-swapped domains from simian-human immunodeficiency virus (SHIV)-infected macaques that neutralized heterologous HIV-1 isolates. FDG precursors were boosted by vaccination in macaques, and were present in HIV-1-naïve humans with an average estimated frequency of one per 340,000 B cells. These data demonstrate frequent HIV-1 Env glycan-reactive bnAb B cell precursors in macaques and humans and reveal a novel strategy for their induction by vaccination. ### Competing Interest Statement The authors have declared no competing interest.

Download data

• Downloaded 262 times
• Download rankings, all-time:
  • Site-wide: 69,573 out of 103,851
  • In immunology: 2,054 out of 3,257
• Year to date:
  • Site-wide: 22,319 out of 103,851
• Since beginning of last month:
  • Site-wide: 14,149 out of 103,851

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide